From Metabolic Health to Pain Relief: Assessing the Role of GLP-1 Therapies in Musculoskeletal Pain
11:00 am - Thursday 28th January 2027
- Exploring the mechanisms through which GLP-1 therapies may influence pain, inflammation, and physical function
- Examining emerging clinical evidence supporting incretin-based approaches in musculoskeletal disorders
- Applying lessons from recent trials to better evaluate efficacy in pain indications
- Improving assay sensitivity and clinical trial execution to accelerate development of next-generation